New Class Action Alleges Ardent Health Misrepresented Receivables, Sets March 9 Deadline
ARDT sits 17% above its 52-week low of $8.07.
Summary
A new securities fraud class action lawsuit has been filed against Ardent Health by Bleichmar Fonti & Auld LLP, alleging the company misrepresented its accounts receivable by delaying the recognition of uncollectable accounts through a '180-day cliff' policy. This follows a previous announcement of a class action lawsuit against the company. The lawsuit claims these alleged misrepresentations led to a significant 33% stock drop on November 13, 2025, after the company revealed a $43 million decrease in revenue and increased professional liability reserves. This development escalates the legal challenges and potential financial liabilities for Ardent Health. Investors have until March 9, 2026, to apply to be appointed as lead plaintiff in the case.
At the time of this announcement, ARDT was trading at $9.48 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $8.07 to $15.55. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Acceswire.